Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

The Choice of Neuromuscular Blockade Reversal Agent and Its Effects on Postoperative Urinary Retention: A Retrospective Cohort Study

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT06948409
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:28:34.414367+00:00
Published At
2026-01-23T00:00:00+00:00
Record Updated At
2026-01-23
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Neuromuscular Blocking Agents", "Urinary Retention After Procedure", "Urinary Retention Postoperative", "Neuromuscular Blockade Reversal Agent", "Neuromuscular Blockade", "Costs", "Atropine", "Sugammadex", "Glycopyrrolate", "Neostigmine", "Anesthesia"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-01-23"
protocolSection.identificationModule.nctId
"NCT06948409"
protocolSection.identificationModule.officialTitle
"The Choice of Neuromuscular Blockade Reversal Agent and Its Effects on Postoperative Urinary Retention: A Retrospective Cohort Study"
protocolSection.statusModule.overallStatus
"ACTIVE_NOT_RECRUITING"
protocolSection.designModule.phases
[]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Neuromuscular Blocking Agents (protocolSection.conditionsModule.conditions)
  • Urinary Retention After Procedure (protocolSection.conditionsModule.conditions)
  • Urinary Retention Postoperative (protocolSection.conditionsModule.conditions)
  • Neuromuscular Blockade Reversal Agent (protocolSection.conditionsModule.conditions)
  • Neuromuscular Blockade (protocolSection.conditionsModule.conditions)
  • Costs (protocolSection.conditionsModule.conditions)
  • Atropine (protocolSection.conditionsModule.conditions)
  • Sugammadex (protocolSection.conditionsModule.conditions)
  • Glycopyrrolate (protocolSection.conditionsModule.conditions)
  • Neostigmine (protocolSection.conditionsModule.conditions)
  • Anesthesia (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.